Pfizer Czech Republic - Profits & Sales

Net Profit & Sales (CZK mil)
Pharmaceutical | Czech Republic | November 10, 2018
$2.99
Excel Sheet

Pfizer Czech Republic made a net profit of CZK 103 mil in 2017, up 39.7% when compared to the last year. Total sales reached CZK 3,586 mil, which is up 10.6% when compared to the previous year.

Historically, the company’s net profit reached an all time high of CZK 272 mil in 2008 and an all time low of CZK -29.9 mil in 2005.

In terms of sales, Pfizer Czech Republic reached an all time high of CZK 6,807 mil in 2011 and an all time low of CZK 2,057 mil in 2003.

Pfizer Czech Republic's net profit has grown 16.4% a year on average in the last five years while sales have increased by 2.84% a year since 2012.

The firm generated its shareholders an average return on invested capital of 10.7% in the last five years.

As far as Pfizer Czech Republic's peers are concerned, Bayer Czech Republic posted a net profit and sales of CZK 106 mil and CZK 4,180 mil in 2017 and Amgen Czech Republic generated a net profit of CZK 37.8 mil (with sales of CZK 417 mil).

You can see all the company’s data at Pfizer Czech Republic Profile, or you can download a report on the company in the report section.

Net Profit Unit 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil 46.2 28.3 28.7 40.5 35.8
Bayer Czech Republic CZK mil 166 83.4 96.2 107 123
GlaxoSmithKline Czech Republic CZK mil 240 164 127 87.7 125
Merck Czech Republic CZK mil 49.3 63.4 27.4 34.9 68.6
Novartis Czech Republic CZK mil 41.7 50.0 52.3 82.2 82.7
Pfizer Czech Republic CZK mil 231 48.1 144 134 75.4
Roche Czech Republic CZK mil 50.5 38.7 135 94.9 51.0 ...
Sanofi-Aventis Czech Republic CZK mil 55.1 45.2 65.2 1.19 58.6
Servier Czech Republic CZK mil ... ... 12.8 13.6 13.6 15.9
Walmark CZK mil 214 -3.00 -8.61 41.8 -716
AVERAGE CZK mil 82.6 122 53.1 68.1 63.7 -7.96 58.2 65.9